SCHEMBL7103744

SCHEMBL7103744

COc1cncc(NN2CCCCC2)c1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SCN10A Q9Y5Y9 1/20 0.44
CHRNB2 P17787 4/20 0.43
CHRNA4 P43681 4/20 0.43
ULK1 O75385 1/20 0.38
ULK2 Q8IYT8 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
CHRNB4 P30926 2/20 0.37
CHRNA3 P32297 2/20 0.37
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
SLC22A12 Q96S37 1/20 0.36
HTT P42858 1/20 0.35
GALR2 O43603 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
GRM5 P41594 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7097803 1.00 SCN10A (0.44) SCN10ACHRNB2CHRNA4ULK1ULK2
SCHEMBL7102415 0.98 CHRNB2 (0.44) SCN10ACHRNB2CHRNA4ULK1ULK2
SCHEMBL7055546 0.75 NPC1 (0.58) NPC1RAB9AHTTGALR2HRH3
SCHEMBL7100975 0.75 ROCK2 (0.36) CHRNB4CHRNA3GRM5SMN1; SMN2
SCHEMBL7098027 0.75 ROCK2 (0.36) CHRNB4CHRNA3GRM5SMN1; SMN2
SCHEMBL7105349 0.74 CHRNB2 (0.45) CHRNB2CHRNA4CHRNB4CHRNA3GRM5
SCHEMBL7481887 0.74 CHRNB2 (0.45) CHRNB2CHRNA4CHRNB4CHRNA3GRM5
SCHEMBL6364424 0.73 HTT (0.57) NPC1RAB9AHTTGALR2HRH3
SCHEMBL7102129 0.73 ROCK2 (0.34) CHRNB4CHRNA3CYP11B1CYP11B2
SCHEMBL7100954 0.72 CHRNB2 (0.46) CHRNB2CHRNA4CHRNB4CHRNA3GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003500402-A 2003-01-07 JP claimed
EP-1178982-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2002-02-13 EP claimed
WO-2000071534-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2000-11-30 WO claimed
EP-1178982-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2002-02-13 EP disclosed
WO-2000071534-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2000-11-30 WO disclosed